Elanco Animal Health (MEX:ELAN) Short-Term Debt: MXN1,274 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ELAN Elanco Animal Health Inc MEX:ELAN
69 GF Score
Price MXN392.00
GF Value MXN268.73
! 4 Warning Signs
View Full Analysis

What is Elanco Animal Health Short-Term Debt?

Elanco Animal Health MEX:ELAN 69 Short-Term Debt is MXN1,274 Mil as of Jun. 2026. GuruFocus rates MEX:ELAN with a GF Score™ of 69/100 and a GF Value™ of MXN268.73. The stock has 4 warning signs investors should review.

Elanco Animal Health's Short-Term Debt for the quarter that ended in Jun. 2026 was MXN1,274 Mil.

Elanco Animal Health's quarterly Short-Term Debt declined from Dec. 2025 (MXN1,332 Mil) to Mar. 2026 (MXN1,316 Mil) and declined from Mar. 2026 (MXN1,316 Mil) to Jun. 2026 (MXN1,274 Mil).

Elanco Animal Health's annual Short-Term Debt increased from Dec. 2023 (MXN645 Mil) to Dec. 2024 (MXN918 Mil) and increased from Dec. 2024 (MXN918 Mil) to Dec. 2025 (MXN1,332 Mil).

Elanco Animal Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Elanco Animal Health Short-Term Debt Related Terms

Elanco Animal Health Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Elanco Animal Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanco Animal Health Short-Term Debt Chart

Elanco Animal Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,031.12 7,564.45 645.02 917.65 1,332.42

Elanco Animal Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,148.58 1,137.34 1,332.42 1,316.39 1,273.78
MEX:ELAN
69GF Score
Elanco Animal Health Inc MEX:ELAN
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of MXN1,274 Mil mean?
Elanco Animal Health (MEX:ELAN) has a Short-Term Debt of MXN1,274 Mil as of Jun. 2026.
Is Elanco Animal Health's Short-Term Debt too high?
Elanco Animal Health's current Short-Term Debt is MXN1,274 Mil. Overall, Elanco Animal Health has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Elanco Animal Health's Short-Term Debt compare to ALKS and LQDA?
Elanco Animal Health's Short-Term Debt of MXN1,274 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Elanco Animal Health's current Short-Term Debt is MXN1,274 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elanco Animal Health stock overvalued right now?
Elanco Animal Health (MEX:ELAN) has a current Short-Term Debt of MXN1,274 Mil. The stock's GF Value™ is MXN268.73, compared to a current price of MXN392.00 — trading 45.9% above its estimated fair value. The current Short-Term Debt is MXN1,274 Mil. Elanco Animal Health's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Elanco Animal Health (MEX:ELAN), the current Short-Term Debt is MXN1,274 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elanco Animal Health (MEX:ELAN) Overvalued in 2026?

Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued. The current stock price of MXN392.00 is trading 45.9% above its estimated GF Value™ of MXN268.73.

Key valuation signals for MEX:ELAN:

  • Short-Term Debt: MXN1,274 Mil
  • GF Value™: MXN268.73 vs. price of MXN392.00 (45.9% above fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the MEX:ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elanco Animal Health Business Description

Other Exchanges ELAN:USA5EA:Germany
Address 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
69GF Score

Get the complete analysis for MEX:ELAN

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN392.00
Price
MXN268.73
GF Value